M/Z: 721.4829
Hit 4 annotations: Lupeoside_[M+H]+
; PE-NMe(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))_[M-H2O+NH4]+
; PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))_[M+H]+
; PS(15:0/16:0)_[M]+
- Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
- Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
- Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
- Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。
Found 15 Reference Ions Near m/z 721.4829
NovoCell ID | m/z | Mass Window | Metabolite | Ranking | Anatomy Context |
---|---|---|---|---|---|
MSI_000007644 Reliable | 721.4774 | 721.4772 ~ 721.4777 MzDiff: 1.9 ppm |
Lupeoside (BioDeep_00000035734) Formula: C41H68O10 (720.4812) |
4.36 (100%) | Rattus norvegicus [UBERON:0004359] corpus epididymis |
MSI_000043606 Reliable | 721.4833 | 721.4831 ~ 721.4837 MzDiff: 2.6 ppm |
Lupeoside (BioDeep_00000035734) Formula: C41H68O10 (720.4812) |
5.7 (50%) | Homo sapiens [UBERON:0001043] esophagus |
MSI_000046887 Reliable | 721.4833 | 721.4831 ~ 721.4837 MzDiff: 2.6 ppm |
Lupeoside (BioDeep_00000035734) Formula: C41H68O10 (720.4812) |
5.7 (50%) | Homo sapiens [UBERON:0001043] esophagus |
MSI_000057846 Unreliable | 721.4816 | 721.4815 ~ 721.4818 MzDiff: 1.5 ppm |
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (BioDeep_00000107205) Formula: C41H69O8P (720.473) |
5.62 (80%) | Homo sapiens [UBERON:0001043] esophagus |
MSI_000047815 Unreliable | 721.4881 | 721.4881 ~ 721.4881 MzDiff: none |
PS(15:0/16:0) (BioDeep_00000104643) Formula: C37H72NO10P (721.4894) |
2.08 (100%) | Homo sapiens [UBERON:0013067] colorectal mucosa |
MSI_000051839 Unreliable | 721.4881 | 721.4881 ~ 721.4881 MzDiff: none |
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (BioDeep_00000107205) Formula: C41H69O8P (720.473) |
2.42 (100%) | Homo sapiens [UBERON:0001052] rectum |
MSI_000021763 Unreliable | 721.4781 | 721.4781 ~ 721.4781 MzDiff: none |
Lupeoside (BioDeep_00000035734) Formula: C41H68O10 (720.4812) |
0.67 (100%) | Mus musculus [UBERON:0001499] muscle of arm |
MSI_000021994 Unreliable | 721.4845 | 721.4845 ~ 721.4845 MzDiff: none |
PE-NMe(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (BioDeep_00000105365) Formula: C40H68NO8P (721.4682) |
0.51 (100%) | Mus musculus [UBERON:0001499] muscle of arm |
MSI_000027541 Unreliable | 721.4795 | 721.4795 ~ 721.4796 MzDiff: 0.3 ppm |
Lupeoside (BioDeep_00000035734) Formula: C41H68O10 (720.4812) |
3.08 (100%) | Mus musculus [UBERON:0002048] lung |
MSI_000022996 Unreliable | 721.4781 | 721.4781 ~ 721.4781 MzDiff: none |
Lupeoside (BioDeep_00000035734) Formula: C41H68O10 (720.4812) |
0.74 (100%) | Mus musculus [UBERON:0004250] upper arm bone |
MSI_000025722 Unreliable | 721.485 | 721.485 ~ 721.485 MzDiff: none |
PE-NMe(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (BioDeep_00000105365) Formula: C40H68NO8P (721.4682) |
2.15 (100%) | Mus musculus [UBERON:0000913] interstitial fluid |
MSI_000031061 Unreliable | 721.4811 | 721.4811 ~ 721.4811 MzDiff: none |
Lupeoside (BioDeep_00000035734) Formula: C41H68O10 (720.4812) |
2.62 (100%) | Macropus giganteus [UBERON:0006093] precuneus cortex |
MSI_000032083 Unreliable | 721.4777 | 721.4777 ~ 721.4777 MzDiff: none |
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (BioDeep_00000107205) Formula: C41H69O8P (720.473) |
2.45 (100%) | Posidonia oceanica [PO:0005020] vascular bundle |
MSI_000035023 Unavailable | 721.4777 | 721.4777 ~ 721.4777 MzDiff: none |
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (BioDeep_00000107205) Formula: C41H69O8P (720.473) |
-0.39 (100%) | Posidonia oceanica [PO:0006036] root epidermis |
MSI_000056301 Unavailable | 721.4837 | 721.4837 ~ 721.4837 MzDiff: none |
Lupeoside (BioDeep_00000035734) Formula: C41H68O10 (720.4812) |
-0.61 (100%) | Homo sapiens [UBERON:0007779] transudate |
Found 34 Sample Hits
Metabolite | Species | Sample | |
---|---|---|---|
Lupeoside Formula: C41H68O10 (720.4812) Adducts: [M+H]+ (Ppm: 14.4) |
Mus musculus (Lung) |
image1Resolution: 40μm, 187x165
Fig. 2 MALDI-MSI data from the same mouse lung tissue analyzed in Fig. 1. A: Optical image of the post-MSI, H&E-stained tissue section. B–D, F–G: Ion images of (B) m/z 796.6855 ([U13C-DPPC+Na]+), (C) m/z 756.5514 ([PC32:0+Na]+), (D) m/z 765.6079 ([D9-PC32:0+Na]+), (F) m/z 754.5359 ([PC32:1+Na]+), and (G) m/z 763.5923 ([D9-PC32:1+Na]+). E, H: Ratio images of (E) [D9-PC32:0+Na]+:[PC32:0+Na]+ and (H) [D9-PC32:1+Na]+:[PC32:1+Na]+. Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. U13C-DPPC, universally 13C-labeled dipalmitoyl PC; PC, phosphatidylcholine; MSI, mass spectrometry imaging; H&E, hematoxylin and eosin.
Fig 1-3, Fig S1-S3, S5 |
|
PE-NMe(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)) Formula: C40H68NO8P (721.4682) Adducts: [M-H2O+NH4]+ (Ppm: 9.7) |
Mus musculus (Left upper arm) |
357_l_total ion countResolution: 50μm, 97x131
Diseased |
|
Lupeoside Formula: C41H68O10 (720.4812) Adducts: [M+H]+ (Ppm: 8.7) |
Mus musculus (Lung) |
image3Resolution: 40μm, 146x190
Fig. 4 MALDI-MSI data of mouse lung tissue after administration with D9-choline and U13C-DPPC–containing Poractant alfa surfactant (labels administered 12 h prior to tissue collection). Ion images of (A) m/z 796.6856 ([U13C-DPPC+Na]+), (B) m/z 756.5154 [PC32:0+Na]+), and (C) m/z 765.6079 ([D9-PC32:0+Na]+). D: Overlay image of [U13C-PC32:0+Na]+ (red) and [D9-PC32:0+Na]+ (green). Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC. |
|
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Formula: C41H69O8P (720.473) Adducts: [M+H]+ (Ppm: 10.3) |
Mus musculus (Lung) |
image4Resolution: 40μm, 162x156
Fig 6c
Fig. 6 MALDI-MSI of U13C-PC16:0/16:0 acyl chain remodeling. A: Averaged MALDI mass spectrum from lung tissue collected from mice euthanized 12 h after administration of D9-choline and U13C-DPPC–containing Poractant alfa surfactant. The ion at m/z 828.6321 is assigned as the [M+Na]+ ion of 13C24-PC16:0_20:4 formed by acyl remodeling of U13C-PC16:0/16:0. The “NL” value refers to the intensity of the base peak in the full range MS1 spectrum. B: MS/MS spectrum of precursor ions at m/z 828.5 ± 0.5 with fragment ions originating from [13C24-PC16:0_20:4+Na]+ annotated. Part-per-million (ppm) mass errors are provided in parentheses. C, D: MALDI-MSI data of [U13C-DPPC+Na]+ (blue), [PC36:4+Na]+ (green) and [13C24-PC16:0_20:4+Na]+ (red) in lung tissue collected from mice (C) 12 h and (D) 18 h after label administration. All images were visualized using total-ion-current normalization and hotspot removal (high quantile = 99%). MS/MS, tandem mass spectrometry; MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC. |
|
Lupeoside Formula: C41H68O10 (720.4812) Adducts: [M+H]+ (Ppm: 9) |
Mus musculus (Lung) |
image4Resolution: 40μm, 162x156
Fig 6c
Fig. 6 MALDI-MSI of U13C-PC16:0/16:0 acyl chain remodeling. A: Averaged MALDI mass spectrum from lung tissue collected from mice euthanized 12 h after administration of D9-choline and U13C-DPPC–containing Poractant alfa surfactant. The ion at m/z 828.6321 is assigned as the [M+Na]+ ion of 13C24-PC16:0_20:4 formed by acyl remodeling of U13C-PC16:0/16:0. The “NL” value refers to the intensity of the base peak in the full range MS1 spectrum. B: MS/MS spectrum of precursor ions at m/z 828.5 ± 0.5 with fragment ions originating from [13C24-PC16:0_20:4+Na]+ annotated. Part-per-million (ppm) mass errors are provided in parentheses. C, D: MALDI-MSI data of [U13C-DPPC+Na]+ (blue), [PC36:4+Na]+ (green) and [13C24-PC16:0_20:4+Na]+ (red) in lung tissue collected from mice (C) 12 h and (D) 18 h after label administration. All images were visualized using total-ion-current normalization and hotspot removal (high quantile = 99%). MS/MS, tandem mass spectrometry; MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC. |
|
Lupeoside Formula: C41H68O10 (720.4812) Adducts: [M+H]+ (Ppm: 12.3) |
Mus musculus (Lung) |
image5Resolution: 40μm, 163x183
Supplementary Figure S8. MALDI-MSI data of mouse lung tissue administered with D9-choline and
U 13C-DPPC–containing Poractant alfa surfactant (labels administered 18 h prior to sacrifice). Ion
images of (a) m/z 796.6856 ([U13C-DPPC+Na]+), (b) m/z 756.5154 [PC32:0+Na]+ and (c) m/z 765.6079
([D9-PC32:0+Na]+). (d) Overlay image of [U13C-DPPC+Na]+ (red) and [D9-PC32:0+Na]+ (green).
Parts per million (ppm) mass errors are indicated in parentheses. All images were visualised using totalion-current normalisation and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. |
|
Lupeoside Formula: C41H68O10 (720.4812) Adducts: [M+H]+ (Ppm: 12.5) |
Mus musculus (Lung) |
image2Resolution: 40μm, 550x256
Supplementary Figure S6. Ion distribution images for (a) [PC36:4+Na]+ (m/z 804.5514) and (b)
[PC38:6+Na]+ (m/z 828.5515) obtained from mouse lung tissue collected 6 h after administration of D9-
choline and U13C-DPPC–containing CHF5633. Parts-per-million (ppm) mass errors are indicated in
parentheses. (c) Magnification of the boxed region in (a) with selected bronchiolar regions outlined in
white boxes. (d) The corresponding H&E-stained tissue section with the same selected bronchiolar
regions outlined in black boxes. These data demonstrate the co-localisation of the polyunsaturated lipids
PC36:4 and PC38:6 with the bronchiolar regions of the lung. All MSI images were visualised using
total ion current normalisation and hotspot removal (high quantile = 99%). |
|
Lupeoside Formula: C41H68O10 (720.4812) Adducts: [M+H]+ (Ppm: 10.3) |
Macropus giganteus (Brain) |
170321_kangaroobrain-dan3-pos_maxof50.0_med1Resolution: 50μm, 81x50
Sample information
Organism: Macropus giganteus (kangaroo)
Organism part: Brain
Condition: Wildtype
Sample growth conditions: Wild |
|
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Formula: C41H69O8P (720.473) Adducts: [M+H]+ (Ppm: 3.5) |
Posidonia oceanica (root) |
20190614_MS1_A19r-20Resolution: 17μm, 262x276
Seagrasses are one of the most efficient natural sinks of carbon dioxide (CO2) on Earth. Despite covering less than 0.1% of coastal regions, they have the capacity to bury up to 10% of marine organic matter and can bury the same amount of carbon 35 times faster than tropical rainforests. On land, the soil’s ability to sequestrate carbon is intimately linked to microbial metabolism. Despite the growing attention to the link between plant production, microbial communities, and the carbon cycle in terrestrial ecosystems, these processes remain enigmatic in the sea. Here, we show that seagrasses excrete organic sugars, namely in the form of sucrose, into their rhizospheres. Surprisingly, the microbial communities living underneath meadows do not fully use this sugar stock in their metabolism. Instead, sucrose piles up in the sediments to mM concentrations underneath multiple types of seagrass meadows. Sediment incubation experiments show that microbial communities living underneath a meadow use sucrose at low metabolic rates. Our metagenomic analyses revealed that the distinct community of microorganisms occurring underneath meadows is limited in their ability to degrade simple sugars, which allows these compounds to persist in the environment over relatively long periods of time. Our findings reveal how seagrasses form blue carbon stocks despite the relatively small area they occupy. Unfortunately, anthropogenic disturbances are threatening the long-term persistence of seagrass meadows. Given that these sediments contain a large stock of sugars that heterotopic bacteria can degrade, it is even more important to protect these ecosystems from degradation. |
|
Lupeoside Formula: C41H68O10 (720.4812) Adducts: [M+H]+ (Ppm: 7.8) |
Homo sapiens (esophagus) |
LNTO22_1_3Resolution: 75μm, 121x68
|
|
Lupeoside Formula: C41H68O10 (720.4812) Adducts: [M+H]+ (Ppm: 12.5) |
Homo sapiens (esophagus) |
LNTO22_1_4Resolution: 17μm, 82x80
|
|
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Formula: C41H69O8P (720.473) Adducts: [M+H]+ (Ppm: 2.1) |
Homo sapiens (esophagus) |
LNTO29_16_2Resolution: 17μm, 95x101
|
|
Lupeoside Formula: C41H68O10 (720.4812) Adducts: [M+H]+ (Ppm: 7.5) |
Homo sapiens (esophagus) |
LNTO22_1_9Resolution: 75μm, 89x74
|
|
PE-NMe(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)) Formula: C40H68NO8P (721.4682) Adducts: [M-H2O+NH4]+ (Ppm: 7.7) |
Mus musculus (Liver) |
Salmonella_final_pos_recalResolution: 17μm, 691x430
A more complete and holistic view on host–microbe interactions is needed to understand the physiological and cellular barriers that affect the efficacy of drug treatments and allow the discovery and development of new therapeutics. Here, we developed a multimodal imaging approach combining histopathology with mass spectrometry imaging (MSI) and same section imaging mass cytometry (IMC) to study the effects of Salmonella Typhimurium infection in the liver of a mouse model using the S. Typhimurium strains SL3261 and SL1344. This approach enables correlation of tissue morphology and specific cell phenotypes with molecular images of tissue metabolism. IMC revealed a marked increase in immune cell markers and localization in immune aggregates in infected tissues. A correlative computational method (network analysis) was deployed to find metabolic features associated with infection and revealed metabolic clusters of acetyl carnitines, as well as phosphatidylcholine and phosphatidylethanolamine plasmalogen species, which could be associated with pro-inflammatory immune cell types. By developing an IMC marker for the detection of Salmonella LPS, we were further able to identify and characterize those cell types which contained S. Typhimurium.
[dataset] Nicole Strittmatter. Holistic Characterization of a Salmonella Typhimurium Infection Model Using Integrated Molecular Imaging, metabolights_dataset, V1; 2022. https://www.ebi.ac.uk/metabolights/MTBLS2671. |
|
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Formula: C41H69O8P (720.473) Adducts: [M+H]+ (Ppm: 1.7) |
Homo sapiens (esophagus) |
LNTO30_8M_1Resolution: 17μm, 69x54
|
|
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Formula: C41H69O8P (720.473) Adducts: [M+H]+ (Ppm: 1) |
Homo sapiens (colorectal adenocarcinoma) |
80TopL, 50TopR, 70BottomL, 60BottomR-profileResolution: 17μm, 137x136
The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024). |
|
PS(15:0/16:0) Formula: C37H72NO10P (721.4894) Adducts: [M]+ (Ppm: 1) |
Homo sapiens (colorectal adenocarcinoma) |
80TopL, 50TopR, 70BottomL, 60BottomR-profileResolution: 17μm, 137x136
The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024). |
|
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Formula: C41H69O8P (720.473) Adducts: [M+H]+ (Ppm: 7) |
Homo sapiens (colorectal adenocarcinoma) |
520TopL, 490TopR, 510BottomL, 500BottomR-profileResolution: 17μm, 147x131
The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024). |
|
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Formula: C41H69O8P (720.473) Adducts: [M+H]+ (Ppm: 1.2) |
Homo sapiens (NA) |
160TopL,130TopR,150BottomL,140BottomR-profileResolution: 17μm, 142x136
|
|
Lupeoside Formula: C41H68O10 (720.4812) Adducts: [M+H]+ (Ppm: 9.6) |
Homo sapiens (esophagus) |
LNTO29_16_3Resolution: 17μm, 108x107
|
|
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Formula: C41H69O8P (720.473) Adducts: [M+H]+ (Ppm: 4.1) |
Homo sapiens (esophagus) |
LNTO26_7_1Resolution: 17μm, 75x74
|
|
Lupeoside Formula: C41H68O10 (720.4812) Adducts: [M+H]+ (Ppm: 6.7) |
Homo sapiens (esophagus) |
LNTO26_7_2Resolution: 17μm, 135x101
|
|
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Formula: C41H69O8P (720.473) Adducts: [M+H]+ (Ppm: 3.4) |
Homo sapiens (esophagus) |
LNTO26_7_3Resolution: 75μm, 82x88
|
|
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Formula: C41H69O8P (720.473) Adducts: [M+H]+ (Ppm: 3.4) |
Homo sapiens (esophagus) |
TO29TResolution: 75μm, 56x48
|
|
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Formula: C41H69O8P (720.473) Adducts: [M+H]+ (Ppm: 2.4) |
Homo sapiens (esophagus) |
LNTO30_17_2Resolution: 75μm, 82x54
|
|
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Formula: C41H69O8P (720.473) Adducts: [M+H]+ (Ppm: 4.4) |
Homo sapiens (esophagus) |
LNTO22_1_5Resolution: 75μm, 135x94
|
|
Lupeoside Formula: C41H68O10 (720.4812) Adducts: [M+H]+ (Ppm: 7.8) |
Homo sapiens (esophagus) |
LNTO22_1_7Resolution: 75μm, 69x54
|
|
Lupeoside Formula: C41H68O10 (720.4812) Adducts: [M+H]+ (Ppm: 8.2) |
Homo sapiens (esophagus) |
LNTO22_1_8Resolution: 75μm, 69x61
|
|
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Formula: C41H69O8P (720.473) Adducts: [M+H]+ (Ppm: 3.2) |
Homo sapiens (esophagus) |
LNTO22_2_1Resolution: 75μm, 89x88
|
|
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Formula: C41H69O8P (720.473) Adducts: [M+H]+ (Ppm: 3.8) |
Homo sapiens (esophagus) |
LNTO22_2_2Resolution: 75μm, 135x94
|
|
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Formula: C41H69O8P (720.473) Adducts: [M+H]+ (Ppm: 3.7) |
Homo sapiens (esophagus) |
LNTO26_16_1Resolution: 75μm, 95x88
|
|
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Formula: C41H69O8P (720.473) Adducts: [M+H]+ (Ppm: 2) |
Homo sapiens (esophagus) |
LNTO29_18_2Resolution: 75μm, 62x68
|
|
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Formula: C41H69O8P (720.473) Adducts: [M+H]+ (Ppm: 1.9) |
Homo sapiens (esophagus) |
LNTO30_7_1Resolution: 75μm, 69x68
|
|
PA(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) Formula: C41H69O8P (720.473) Adducts: [M+H]+ (Ppm: 1.7) |
Homo sapiens (colorectal adenocarcinoma) |
240TopL, 210TopR, 230BottomL, 220BottomR-centroidResolution: 50μm, 142x141
|
|